Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gabriella Fabbrocini

Showing results (81-90 of 624) with videos related to

Pageof 63
Sort By:
Case Reports in Dermatology|October 1, 2020
A Case of Ofuji Disease Successfully Treated with the Combination of Low-Dose Indomethacin and Topical TacrolimusClaudio Marasca, Angelo Ruggiero, Gabriella Fabbrocini, et al.
Dermatologic Therapy|December 14, 2020
Efficacy and safety of guselkumab in psoriasis patients who failed ustekinumab and/or anti-interleukin-17 treatment: A real-life 52-week retrospective studyAngelo Ruggiero, Gabriella Fabbrocini, Eleonora Cinelli, et al.
Journal of the American Academy of Dermatology|March 7, 2021
Response to "Efficacy of sonidegib in histologic subtypes of advanced basal cell carcinoma: Results from the final analysis of the randomized phase 2 Basal Cell Carcinoma Outcomes with LDE225 Treatment (BOLT) trial at 42 months"Alessia Villani, Gabriella Fabbrocini, Claudia Costa, et al.
Dermatologic Therapy|November 20, 2021
Real world practice indirect comparison between guselkumab and risankizumab: Results from an Italian retrospective studyAngelo Ruggiero, Gabriella Fabbrocini, Eleonora Cinelli, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|October 13, 2022
Reply to 'A case of pityriasis lichenoides et varioliformis acuta developed after first dose of Oxford-AstraZeneca COVID-19 vaccine'Fabrizio Martora, Gabriella Fabbrocini, Gianluca Guerrasio, et al.
Advances in Therapy|January 28, 2022
New Emerging Treatment Options for Advanced Basal Cell Carcinoma and Squamous Cell CarcinomaAlessia Villani, Luca Potestio, Gabriella Fabbrocini, et al.
JAAD Case Reports|March 21, 2022
Hidradenitis suppurativa flares following COVID-19 vaccination: A case seriesFabrizio Martora, Vincenzo Picone, Gabriella Fabbrocini, et al.
Skin Appendage Disorders|April 14, 2022
An Unusual Case of Pemphigus VulgarisLaura Marano, Gabriella Fabbrocini, Giuseppe Monfrecola, et al.
Mycoses|May 8, 2019
A 15-year retrospective study on the prevalence of onychomycosis in psoriatic vs non-psoriatic patients: A new European shift from dermatophytes towards yeastLucia Gallo, Eleonora Cinelli, Gabriella Fabbrocini, et al.
The Australasian Journal of Dermatology|April 28, 2023
A case of multiple basal cell carcinomas in an immunocompromised skin district: The aetiopathogenetic role of congenital lymphqedemaVincenzo Picone, Alessia Villani, Federica Feo, et al.
Pageof 63

Showing results (81-90 of 624) with videos related to

Sort By:
Pageof 63
Case Reports in Dermatology|October 1, 2020
A Case of Ofuji Disease Successfully Treated with the Combination of Low-Dose Indomethacin and Topical TacrolimusClaudio Marasca, Angelo Ruggiero, Gabriella Fabbrocini, et al.
Dermatologic Therapy|December 14, 2020
Efficacy and safety of guselkumab in psoriasis patients who failed ustekinumab and/or anti-interleukin-17 treatment: A real-life 52-week retrospective studyAngelo Ruggiero, Gabriella Fabbrocini, Eleonora Cinelli, et al.
Journal of the American Academy of Dermatology|March 7, 2021
Response to "Efficacy of sonidegib in histologic subtypes of advanced basal cell carcinoma: Results from the final analysis of the randomized phase 2 Basal Cell Carcinoma Outcomes with LDE225 Treatment (BOLT) trial at 42 months"Alessia Villani, Gabriella Fabbrocini, Claudia Costa, et al.
Dermatologic Therapy|November 20, 2021
Real world practice indirect comparison between guselkumab and risankizumab: Results from an Italian retrospective studyAngelo Ruggiero, Gabriella Fabbrocini, Eleonora Cinelli, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|October 13, 2022
Reply to 'A case of pityriasis lichenoides et varioliformis acuta developed after first dose of Oxford-AstraZeneca COVID-19 vaccine'Fabrizio Martora, Gabriella Fabbrocini, Gianluca Guerrasio, et al.
Advances in Therapy|January 28, 2022
New Emerging Treatment Options for Advanced Basal Cell Carcinoma and Squamous Cell CarcinomaAlessia Villani, Luca Potestio, Gabriella Fabbrocini, et al.
JAAD Case Reports|March 21, 2022
Hidradenitis suppurativa flares following COVID-19 vaccination: A case seriesFabrizio Martora, Vincenzo Picone, Gabriella Fabbrocini, et al.
Skin Appendage Disorders|April 14, 2022
An Unusual Case of Pemphigus VulgarisLaura Marano, Gabriella Fabbrocini, Giuseppe Monfrecola, et al.
Mycoses|May 8, 2019
A 15-year retrospective study on the prevalence of onychomycosis in psoriatic vs non-psoriatic patients: A new European shift from dermatophytes towards yeastLucia Gallo, Eleonora Cinelli, Gabriella Fabbrocini, et al.
The Australasian Journal of Dermatology|April 28, 2023
A case of multiple basal cell carcinomas in an immunocompromised skin district: The aetiopathogenetic role of congenital lymphqedemaVincenzo Picone, Alessia Villani, Federica Feo, et al.
Pageof 63